Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2007-01-30 Regulatory Filings
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Commitments Test Entity - Second Quarter Report 6 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4C - Quarterly cash report' and is addressed to the ASX Companies Announcements Office. It contains detailed quarterly cash flow information for the quarter ended 31 December 2006, including operating, investing, and financing cash flows, reconciliation of cash, and compliance statements. The document is a regulatory quarterly cash flow report specific to entities admitted on the basis of commitments, commonly filed with the ASX. It is not a full interim or quarterly report with comprehensive financial statements and analysis, but rather a specific cash flow appendix report. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory announcement of a quarterly cash flow report rather than a full Interim/Quarterly Report (IR).
2007-01-30 English
Issue of employee options 1 page ?Kb
Share Issue/Capital Change Classification · 95% confidence The document is a notification about the issuance of unlisted options to directors and employees, including details such as exercise price and number of options. It references a resolution passed at the annual general meeting but does not contain financial statements or detailed financial performance data. The content is about share options granted, which relates to capital changes but specifically about options issued to insiders. This fits best under the category of Share Issue/Capital Change (SHA) as it announces new share options issued.
2006-11-30 English
Results of AGM 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement from Probiomics Limited to the Australian Stock Exchange regarding the results of resolutions passed at the Annual General Meeting (AGM) held on the same day. It details voting outcomes for multiple resolutions including re-election of a director, adoption of remuneration policy, and issuance of options to directors. The content focuses exclusively on the voting results of the AGM resolutions, which matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2441 characters) and it is not a full report or presentation, but a results announcement. Therefore, the correct classification is DVA with high confidence.
2006-11-28 English
Commitments Test Entity - First Quarter Report 6 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C - Quarterly cash report' and is dated 31st October 2006, covering the quarter ended 30th September 2006. It contains detailed cash flow statements, including operating, investing, and financing activities, with specific quarterly and year-to-date figures. The document also includes compliance statements referencing accounting standards and is addressed to the ASX Companies Announcements Office, indicating it is a regulatory quarterly financial report. The presence of detailed financial data for a quarter and the nature of the report align with an Interim / Quarterly Report (IR) rather than a brief announcement or a full annual report. The length (over 14,000 characters) and detailed financial content confirm it is a substantive quarterly financial report, not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2006
2006-10-30 English
Notice of Annual General Meeting 10 pages ?Kb
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting' and includes an Explanatory Memorandum for the AGM of Probiomics Limited. It details the date, time, and location of the AGM, the agenda including ordinary business such as the re-election of a director, remuneration policy, and issuance of options to directors. It also includes proxy information and voting procedures. The document is clearly a notice and explanatory material for the AGM, not the actual annual report or financial statements. It does not contain financial data or results but rather information to be presented and voted on at the AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2006-10-24 English
Lapse of Unlisted Options 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is a short announcement addressed to the Australian Stock Exchange regarding the lapse of unlisted options and options issued under the company's Employee Share Option Plan. It provides specific details about the class, exercise price, and number of options that have lapsed. There is no financial report, management discussion, or detailed analysis. The document is an update on capital structure changes related to options, which fits the category of Capital/Financing Update (CAP). The document length is short (1120 characters), but it contains substantive information about capital changes, not just a report publication announcement or a regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2006-10-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.